Ferdi Steinmann looks at pharma's current relationship with AI and how it is set to evolve.
Ferdi Steinmann
Advertisement
With nearly 25 years of experience in driving strategy & commercialization efforts in Biotech & Pharma, with an exclusive focus in Life Sciences (LS) strategic planning and industry marketing efforts for enterprise software solutions, Ferdi Steinmann is responsible for the LS global industry strategy development at OpenText.
Articles by Ferdi Steinmann
The Pharma Supply Chain Post-COVID-19: Key Lessons and Opportunities
Published: | Updated:
Ferdi Steinmann outlines a few supply chain lessons that all pharma companies can learn from the COVID-19 pandemic.
Advertisement
Latest Updated Articles
The Pharma Supply Chain Post-COVID-19: Key Lessons and OpportunitiesPublished: August 31st 2020 | Updated: January 6th 2023
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Pharmaceutical Executive Daily: FDA Approves Hernexeos
5